NBIX vs RVMD
Neurocrine Biosciences, Inc. - Common Stock · Revolution Medicines, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | NBIX | RVMD |
|---|---|---|
| Price | $135.91 | $193.52 |
| Market Cap | $13.82B | $41.48B |
| P/E | 28.87 | — |
| P/B | 3.74 | 15.92 |
| P/S | 4.83 | — |
| ROE | 13.0% | -43.4% |
| Net Margin | 16.7% | — |
| Gross Margin | — | — |
| Revenue Growth | 21.4% | — |
| Dividend Yield | — | — |
| EPS | $4.71 | -$5.28 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.